Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD

被引：5
|
作者：
Ray K.
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
Nature Reviews Gastroenterology & Hepatology | 2021年 / 18卷 / 5期
关键词：
D O I：
10.1038/s41575-021-00445-1
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：286 / 286
相关论文
共 50 条
  • [1] Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
    Kennedy, Nicholas A.
    Goodhand, James R.
    Bewshea, Claire
    Nice, Rachel
    Chee, Desmond
    Lin, Simeng
    Chanchlani, Neil
    Butterworth, Jeffrey
    Cooney, Rachel
    Croft, Nicholas M.
    Hart, Ailsa L.
    Irving, Peter M.
    Kok, Klaartje B.
    Lamb, Christopher A.
    Limdi, Jimmy K.
    Macdonald, Jonathan
    McGovern, Dermot Pb
    Mehta, Shameer J.
    Murray, Charles D.
    Patel, Kamal, V
    Pollok, Richard C. G.
    Raine, Timothy
    Russell, Richard K.
    Selinger, Christian P.
    Smith, Philip J.
    Bowden, Jack
    McDonald, Timothy J.
    Lees, Charlie W.
    Sebastian, Shaji
    Powell, Nicholas
    Ahmad, Tariq
    GUT, 2021, 70 (05) : 865 - 875
  • [2] Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic
    Kennedy, Nicholas A.
    Janjua, Malik
    Chanchlani, Neil
    Lin, Simeng
    Bewshea, Claire
    Nice, Rachel
    McDonald, Timothy J.
    Auckland, Cressida
    Harries, Lorna W.
    Davies, Merlin
    Michell, Stephen
    Kok, Klaartje B.
    Lamb, Christopher A.
    Smith, Philip J.
    Hart, Ailsa L.
    Pollok, Richard C. G.
    Lees, Charlie W.
    Boyton, Rosemary J.
    Altmann, Daniel M.
    Sebastian, Shaji
    Powell, Nicholas
    Goodhand, James R.
    Ahmad, Tariq
    GUT, 2023, 72 (02) : 295 - 305
  • [3] Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab
    Kennedy, N. A.
    Goodhand, J.
    Bewshea, C.
    Nice, R.
    Chee, D.
    Lin, S.
    Chanchlani, N.
    Butterworth, J.
    Cooney, R.
    Croft, N.
    Hart, A.
    Irving, P.
    Kok, K.
    Lamb, C.
    Limdi, J.
    MacDonald, J.
    McGovern, D.
    Mehta, S.
    Murray, C.
    Patel, K.
    Pollok, R.
    Raine, T.
    Russell, R.
    Selinger, C.
    Smith, P.
    Bowden, J.
    McDonald, T.
    Lees, C.
    Sebastian, S.
    Powell, N.
    Ahmad, I.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S002 - S004
  • [4] SARS-CoV-2 Vaccine Antibody Response in Patients With IBD
    Garza, Manuel A.
    Saleh, Adam
    Maturi, Vamsi
    Perry, Caroline
    Cho, Su Min
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S373 - S373
  • [5] Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy
    Privitera, Giuseppe
    Pugliese, Daniela
    Scaldaferri, Franco
    Armuzzi, Alessandro
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (06) : 764 - 765
  • [6] SARS-CoV-2: Vaccination effects in IBD Patients treated with Biologics
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (08):
  • [7] Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
    Linderman, Susanne L.
    Lai, Lilin
    Gamarra, Estefany L. Bocangel
    Lau, Max S. Y.
    Edupuganti, Srilatha
    Surie, Diya
    Tenforde, Mark W.
    Chappell, James D.
    Mohr, Nicholas M.
    Gibbs, Kevin W.
    Steingrub, Jay S.
    Exline, Matthew C.
    Shapiro, Nathan I.
    Frosch, Anne E.
    Qadir, Nida
    Davis-Gardner, Meredith E.
    McElrath, M. Juliana
    Lauring, Adam S.
    Suthar, Mehul S.
    Patel, Manish M.
    Self, Wesley H.
    Ahmed, Rafi
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (23):
  • [8] Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
    Choe, Pyoeng Gyun
    Kang, Chang Kyung
    Suh, Hyeon Jeong
    Jung, Jongtak
    Song, Kyoung-Ho
    Bang, Ji Hwan
    Kim, Eu Suk
    Kim, Hong Bin
    Park, Sang Won
    Kim, Nam Joong
    Park, Wan Beom
    Oh, Myoung-Don
    EMERGING INFECTIOUS DISEASES, 2021, 27 (01) : 327 - 329
  • [9] Antibody and B cell responses to SARS-CoV-2 infection and vaccination
    Roltgen, Katharina
    Boyd, Scott D.
    CELL HOST & MICROBE, 2021, 29 (07) : 1063 - 1075
  • [10] IMPACT OF VACCINATION AND INFECTION ON SARS-COV-2 IGG ANTIBODY RESPONSES
    Khatchadourian, V.
    Wakefield, I.
    Pei, R.
    Lowe, D.
    HUMAN IMMUNOLOGY, 2022, 83 : 129 - 130
12345